Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Jeevan Scientific Technology Limited approved unaudited standalone and consolidated results for Q1 FY26 (quarter ended June 30, 2025). Standalone revenue fell to Rs. 821.57 lakhs from Rs. 1,251.66 lakhs a year ago, and the company slipped into a standalone loss of Rs. 215.99 lakhs (vs. a profit of Rs. 160.08 lakhs in Q1 FY25); consolidated loss widened to Rs. 321.91 lakhs. Promoter Krishna Kishore Kuchipudi was re-appointed as Managing Director for 3 years from April 1, 2026 at a remuneration of Rs. 9 lakh per month. Former Principal Commissioner of Income Tax Gollapinni Mallikarjuna was inducted as an additional Independent Director. Two directors – Diwakar Atluri and Jeevan Krishna Kuchipudi – were re-appointed by rotation. Non-Executive Director Thammareddy Ravi resigned citing personal commitments. The board also approved a grant of 3 lakh stock options to employees under the JSTL ESOP Scheme 2016. The AGM is scheduled for September 27, 2025.
The sharp swing to a quarterly loss and a ~34% YoY revenue drop highlight weak operational performance and are likely to weigh on sentiment. Director-level changes are largely routine, and the ESOP grant (3 lakh shares) is small relative to the Rs. 1,583.40 lakh equity base, so dilution impact is minimal.